Dr. Nisha A. Mohindra
Claim this profileNorthwestern University
Area of expertise
Lung Cancer
Nisha A. Mohindra has run 8 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Nisha A. Mohindra has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Northwestern University
Northwestern Medicine Lake Forest Hospital
Clinical Trials Nisha A. Mohindra is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting
1 award
Phase 1
19 criteria
More about Nisha A. Mohindra
Clinical Trial Related
5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Nisha A. Mohindra has experience with
- Carboplatin
- Pembrolizumab
- Paclitaxel
- Pemetrexed
- Atezolizumab
- Cisplatin
Breakdown of trials Nisha A. Mohindra has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Thymic Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nisha A. Mohindra specialize in?
Nisha A. Mohindra focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Nisha A. Mohindra currently recruiting for clinical trials?
Yes, Nisha A. Mohindra is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Nisha A. Mohindra has studied deeply?
Yes, Nisha A. Mohindra has studied treatments such as Carboplatin, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Nisha A. Mohindra?
Apply for one of the trials that Nisha A. Mohindra is conducting.
What is the office address of Nisha A. Mohindra?
The office of Nisha A. Mohindra is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.